QUEBEC CITY, Canada - Atrium Biotechnologies Inc. changed its name Thursday to Atrium Innovations Inc.
The name change is designed to reflect the company’s transition from a subsidiary of a biotechnology company to a multi product manufacturer and marketer and integrated international company.
Pierre Laurin, Chairman of the Board, also announced that Carole St-Charles was appointed to the Board of Atrium Innovations. St-Charles is the president of food and OTC healthcare products company Consortium J.L.F. Inc.
Atrium Innovations develops, manufactures and markets science-based products for the cosmetics, pharmaceutical, chemical and nutrition industries.
